We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ILMN market cap is 17.8B. The company's latest EPS is USD -7.3065 and P/E is -15.56.
| Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.09B | 1.18B | 1.12B | 1.12B | 1.08B |
| Operating Income | -64M | -88M | -753M | -164M | -93M |
| Net Income | 3M | -234M | -755M | -175M | -126M |
| Year End 31 December 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.54B | 3.24B | 4.53B | 4.58B | 4.5B |
| Operating Income | 985M | 580M | -123M | -4.18B | -1.07B |
| Net Income | 1B | 656M | 762M | -4.4B | -1.16B |
| Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.81B | 11.77B | 10.12B | 10.11B | 10.04B |
| Total Liabilities | 5.12B | 5.22B | 4.22B | 4.37B | 4.31B |
| Total Equity | 6.69B | 6.56B | 5.9B | 5.75B | 5.73B |
| Year End 31 December 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.32B | 7.59B | 15.22B | 12.25B | 10.11B |
| Total Liabilities | 2.7B | 2.89B | 4.48B | 5.65B | 4.37B |
| Total Equity | 4.61B | 4.69B | 10.74B | 6.6B | 5.75B |
| Quarter End | Apr 2023 | Jul 2023 | Oct 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10M | 115M | 254M | 478M | 77M |
| Investing | -56M | -93M | -146M | -231M | -48M |
| Financing | -473M | -476M | -1.18B | -1.21B | 35M |
| Year End 31 December 2023 | 2019 | 2021 | 2022 | 2023 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.05B | 1.08B | 545M | 392M | 478M |
| Investing | 745M | -554M | -1.07B | -591M | -231M |
| Financing | -897M | -766M | -51M | 1B | -1.21B |
| Market Cap | 17.8B |
| Price to Earnings Ratio | -15.56 |
| Price to Sales Ratio | 4.01 |
| Price to Cash Ratio | 17.23 |
| Price to Book Ratio | 3.14 |
| Dividend Yield | - |
| Shares Outstanding | 158.9M |
| Average Volume (1 week) | 3.82M |
| Average Volume (1 Month) | 2.17M |
| 52 Week Change | -44.74% |
| 52 Week High | 212.4858 |
| 52 Week Low | 89.00 |
| Spread (Intraday) | 1 (0.88%) |
| Company Name | Illumina Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.illumina.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
